The Journal of clinical endocrinology and metabolism · 2026
Overnight Dexamethasone Suppression Test: Enhanced Accuracy With Late-afternoon Cortisol and Morning/Late-afternoon ACTH.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ban Anuj, Memon Saba Samad, Lila Anurag Ranjan, Karlekar Manjiri, Barnabas Rohit, Yami Channaiah Chethan, Sharma Anima, Phadte Aditya, Sarathi Vijaya, Jamale Tukaram, Shah Nalini, Bandgar Tushar
Аннотация
CONTEXT: The overnight dexamethasone suppression test (ODST) is precise and highly sensitive; however, its specificity ranges from 80% to 90%.
OBJECTIVE: To assess whether late-afternoon overnight dexamethasone suppression (ODS) cortisol and morning/late-afternoon ODS ACTH measurements improve ODST accuracy.
METHODS: Prospective, single-center study included healthy adults (n = 60), combined oral contraceptive pill (COCP) users (n = 29), chronic kidney disease (CKD, n = 29), treatment-naïve ACTH-dependent Cushing syndrome (A-CS, n = 33), posttreatment Cushing disease in remission (CD-R, n = 23) or persistence (CD-P, n = 31). Participants underwent the standard 1-mg dexamethasone suppression test; blood samples were collected at 8 to 9 Am for cortisol, ACTH, dexamethasone and at 3 to 4 Pm for cortisol and ACTH.
RESULTS: ODS 4 Pm cortisol was significantly lower than 8 Am in healthy adults (P = .003), COCP (P < .001), CKD (P < .001), and CD-R (P = .001), whereas this difference was not significant in treatment-naïve A-CS and CD-P. ODS 8 Am and 4 Pm cortisol (cutoff: 1.8 μg/dL) showed high specificity in healthy adults (95% and 100%), but its specificity was low in COCP (55% and 79%) and CKD (17% and 52%). ODS 8 Am and 4 Pm ACTH (cutoff: 10 pg/mL) showed high specificity in healthy adults (95%, 100%), COCP (100%, 100%), and CKD (96.6%, 100%), with 100% sensitivity for diagnosing A-CS. The diagnostic accuracy of ODS 4 Pm cortisol, ODS 8 Am ACTH, and ODS 4 Pm ACTH in differentiating CD-R from CD-P was 98.1%, 81.5% and 81.5%, respectively.
CONCLUSION: Late-afternoon cortisol measurement is a novel modification that enhances ODST specificity. ACTH measurement was particularly useful in COCP and CKD. Before widespread integration in clinical practice, further validation is required.
OBJECTIVE: To assess whether late-afternoon overnight dexamethasone suppression (ODS) cortisol and morning/late-afternoon ODS ACTH measurements improve ODST accuracy.
METHODS: Prospective, single-center study included healthy adults (n = 60), combined oral contraceptive pill (COCP) users (n = 29), chronic kidney disease (CKD, n = 29), treatment-naïve ACTH-dependent Cushing syndrome (A-CS, n = 33), posttreatment Cushing disease in remission (CD-R, n = 23) or persistence (CD-P, n = 31). Participants underwent the standard 1-mg dexamethasone suppression test; blood samples were collected at 8 to 9 Am for cortisol, ACTH, dexamethasone and at 3 to 4 Pm for cortisol and ACTH.
RESULTS: ODS 4 Pm cortisol was significantly lower than 8 Am in healthy adults (P = .003), COCP (P < .001), CKD (P < .001), and CD-R (P = .001), whereas this difference was not significant in treatment-naïve A-CS and CD-P. ODS 8 Am and 4 Pm cortisol (cutoff: 1.8 μg/dL) showed high specificity in healthy adults (95% and 100%), but its specificity was low in COCP (55% and 79%) and CKD (17% and 52%). ODS 8 Am and 4 Pm ACTH (cutoff: 10 pg/mL) showed high specificity in healthy adults (95%, 100%), COCP (100%, 100%), and CKD (96.6%, 100%), with 100% sensitivity for diagnosing A-CS. The diagnostic accuracy of ODS 4 Pm cortisol, ODS 8 Am ACTH, and ODS 4 Pm ACTH in differentiating CD-R from CD-P was 98.1%, 81.5% and 81.5%, respectively.
CONCLUSION: Late-afternoon cortisol measurement is a novel modification that enhances ODST specificity. ACTH measurement was particularly useful in COCP and CKD. Before widespread integration in clinical practice, further validation is required.